REF: 381923 BD Insyte Autoguard Winged Shielded IV Catheter, 22 GA x 1.00 in (0.9 x 25 mm) 35 ...
FDA Device Recall #Z-2006-2025 — Class II — May 21, 2025
Recall Summary
| Recall Number | Z-2006-2025 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 21, 2025 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Becton Dickinson Infusion Therapy Systems, Inc. |
| Location | Sandy, UT |
| Product Type | Devices |
| Quantity | 50 units |
Product Description
REF: 381923 BD Insyte Autoguard Winged Shielded IV Catheter, 22 GA x 1.00 in (0.9 x 25 mm) 35 mL/min, STERILEEO, RxOnly
Reason for Recall
Due to customer complaints, there is the possibility that catheter needle may be slow to retract or fail to retract.
Distribution Pattern
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV and the countries of Belgium, Canada, Chile, Colombia, Guatemala, Japan, New Zealand, Panama, Philippines, Singapore, Vietnam.
Lot / Code Information
Lot# 4282308/UDI: 382903819232
Other Recalls from Becton Dickinson Infusion Therapy Sys...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2007-2025 | Class II | REF: 381434 BD Insyte Autoguard Shielded IV ... | May 21, 2025 |
| Z-2005-2025 | Class II | REF: 382544 BD Insyte Autoguard Shielded IV ... | May 21, 2025 |
| Z-2002-2025 | Class II | REF: 381433, BD Insyte Autoguard Shielded IV Ca... | May 21, 2025 |
| Z-1999-2025 | Class II | REF: 381423, BD Insyte Autoguard, Shielded IV C... | May 21, 2025 |
| Z-2003-2025 | Class II | REF: 382944, BD Insyte Autoguard BC Pro Winged ... | May 21, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.